The vestibular blood-labyrinth barrier (BLB) is comprised of perivascular-resident macrophage-like melanocytes (PVM/Ms) and pericytes (PCs), in addition to endothelial cells (ECs) and basement membrane (BM), and bears strong resemblance to the cochlear BLB in the stria vascularis. Over the past few decades, in vitro cell-based models have been widely used in blood-brain barrier (BBB) and blood-retina barrier (BRB) research, and have proved to be powerful tools for studying cell-cell interactions in their respective organs. Study of both the vestibular and strial BLB has been limited by the unavailability of primary culture cells from these barriers. To better understand how barrier component cells interact in the vestibular system to control BLB function, we developed a novel culture mediumebased method for obtaining EC, PC, and PVM/M primary cells from tiny explants of the semicircular canal, sacculus, utriculus, and ampullae tissue of young mouse ears at post-natal age 8e12 d. Each phenotype is grown in a specific culture medium which selectively supports the phenotype in a mixed population of vestibular cell types. The unwanted phenotypes do not survive passaging. The protocol does not require additional equipment or special enzyme treatment. The harvesting process takes less than 2 h. Primary cell types are generated within 7e10 d. The primary culture ECs, PCs, and PVM/M shave consistent phenotypes more than 90% pure after two passages (~3 weeks). The highly purified primary cell lines can be used for studying cell-cell interactions, barrier permeability, and angiogenesis.
Introduction
The blood-labyrinth barrier (BLB) in the vestibular system tightly regulates the vestibular microenvironment for functional balance and coordination (Rybak, 1995) . Integrity of the barrier is critical for maintaining fluid ion homeostasis in the ear, a sine quanon for signal transduction and vestibular function. Disruption of the BLB has long been considered an etiologic factor in a variety of vestibular disorders, including M eni ere's disease, and meningitis-associated labyrinthitis (Juhn et al., 2001; Laurell et al., 2008; Tagaya et al., 2011; Trune, 1997) . Despite the importance of the BLB to vestibular function, mechanisms that control BLB barrier permeability remain largely unknown. Information on regulation of the BLB in the vestibular system is sparse.
The structure of the BLB in the vestibular system is similar to the BLB of the intra-strial fluid-blood barrier. At the cellular level, the BLB is comprised of cochlear microvascular endothelial cells (ECs) lining cochlear microvessels, associated basement membrane, and a "second line of component cells" including cochlear pericytes (PCs) and perivascular resident macrophage-like melanocytes (PVM/Ms) (Zhang et al., 2013) . The BLB is formed by tight junctions (TJs) between the ECs, like other blood-tissue barriers, but the barrier is further characterized by its carrier-mediated transport system and absence of fenestration (Sakagami et al., 1986) .
Over the past few decades, in vitro cell-based models are widely used in blood-brain-barrier (BBB) and blood-retina-barrier (BRB) studies. The cell line-based in vitro BBB or BRB models have proven to be powerful tools for studying cell-cell interactions and regulation of blood barrier permeability (Cucullo et al., 2002; Duport et al., 1998; Lai and Kuo, 2005) . However, these research tools have been of limited use in studying the BLB due to the difficulty of isolating BLB component cells from the vestibular system. Although different methods of isolation and culture of barrier cells from the brain, retina, skeletal muscle, skin, and fetal tissues have been successfully used to obtain barrier component cells (Bryan and D'Amore, 2008; Crisan et al., 2008; Mogensen et al., 2011; Sundberg et al., 2002) , most of the methods are time-consuming and involve multiple steps of enzymatic digestion, gradient density centrifuging, and glass bead or magnetic separation (Bowman et al., 1983; Bowman et al., 1981; Ohtsuki et al., 2007; Stins et al., 1997) . The techniques are usually performed in non-cochlear tissues from rat (Ohtsuki et al., 2007) , porcine (Mischeck et al., 1989) , or bovine models (Ryan, 1984) where tissue volume is not limited (Ballarin and Peruffo, 2012; Leppens et al., 1996; Xie et al., 1997) . However, the microvasculature in the vestibular system is small in volume and anatomically complex. These constraints have impeded the production of vestibular BLB component cells by commonly used capillary extraction and isolation methods. The difficulty in isolating BLB component cells has limited our understanding the functional role of each cell type in the BLB of the vestibular system.
In this study, we describe a novel method which uses a specifically formulated culture media to selectively grow EC, PC, and PVM/M phenotypes from fragmented young mouse vestibular tissue. The method was earlier developed for production of EC, PC and PVM/M phenotypes from cochlear strial tissue. The method is practicable and provides consistent results. Blood barrier component cells from different organs and tissues show organ and tissue specific differences (Garlanda and Dejana, 1997; Invernici et al., 2005) . Extrapolation of vestibular BLB function using nonvestibular barrier cell lines such as obtained from the cochlea, brain, and kidney may not accurately reflect the physiological features of the BLB. Primary cell lines generated directly from the BLB of the vestibular system enables us to investigate the specific role of each phenotype on BLB integrity and identify vestibular organspecific characteristics of the BLB.
Materials and methods

Animals
C57BL/6J mice, purchased from Jackson Laboratory (Bar Harbor, ME, USA), were inbred and used at age 8e12 d. The protocol for the care and use of these animals was approved by the Institutional Animal Care and Use Committee at Oregon Health & Science University (the IACUC approval number is IS00003678).
Collection of vestibular end-organs from young mouse ears
The mice were anesthetized with ketamine hydrochloride (100 mg/kg, intramuscular) and 2% xylazine hydrochloride (10 mg/ kg, Abbott Laboratories, USA). The auditory bullae was rapidly removed and placed in a Petri dish filled with cold, fresh artificial perilymph solution. The surgery was performed under sterile conditions. The vestibular sacculus, utriculus, and ampullae of the semicircular canal tissue were gently extracted and placed in a cold artificial perilymph solution containing 125 mmol/L NaCl, 3.5 mmol/L KCl, 1.3 mmol/L CaCl 2 , 1.5 mmol/L MgCl 2 , 0.51 mmol/L NaH 2 PO4, 10 mmol/L Hepes, and 5 mmol/L glucose at pH 7.4 with osmolarity adjusted to 310 mmol/kg. Otoliths were gently removed with Dumont tweezers (110 mm, 0.1 Â 0.06 mm tip) and a Tungsten dissecting probe (50 mm, 0.5 mm diameter rod). The tissue was torn into pieces as small as possible under sterile conditions with fine ophthalmic tweezers under an Olympus SZ61 dissecting microscope using the method described by Neng et al. (2013b) . After the tiny fragments of tissue resettled by gravity, they were repositioned to uniform density with a needle (50 mm, 0.5 mm diameter rod). The tiny fragments were then selectively cultured in one of three specific growth media, each specifically formulated to support the growth of either ECs, PCs, or PVM/Ms.
EC, PC, and PVM/M growth media
The growth medium for selection of ECs (100 ml) consisted of 20 ml FBS (fetal bovine serum, catalog # F2442, Sigma), 76 mL CS-C (cell systems corporation) medium without serum (catalog # C1556, Sigma), 1 ml of penicillin-streptomycin solution (catalog # P4333, Sigma), 1 ml of Heparin sodium salt 10 mg/mL (catalog # H3393, Sigma), and 2 ml of ECGF (endothelial cell growth factor, catalog # E9640, Sigma). 0.1 mmol/L Bromodeoxy Uridine (5-Bromo-2-DeoxyUridine, BrdU) (catalog # B5002, Sigma) was added to the EC growth medium on day 2 to suppress non-specific cell growth. The PC growth medium (100 ml) consisted of 10 ml of FBS (catalog # F2442, Sigma), 1 ml of penicillin-streptomycin solution (catalog # P4333, Sigma), 1 ml of PC Growth Supplement 100 Â (catalog # 1252, Science), and 88 ml of DMEM (Dulbecco's modified eagle's medium) low glucose (catalog # 11885-084, Life Technologies). PEDF (pigment epithelium-derived factor, catalog # SRP4988, Sigma) at a concentration of 100 nM was added on day 2 to the PC medium (Yamagishi et al., 2005) . The PVM/M growth medium (100 ml) consisted of 10 ml of FBS (catalog # F2442, Sigma), 20 ml gentamicin/amphotericin B solution (catalog # 50-0640, Life Technologies), 0.2 mMCaCl 2, 1 ml of HMGS (human melanocyte growth supplement, catalog # S-002-5, Life Technologies), and 88.8 ml of medium 254 CF (calcium-free, catalog # M-254CF-500, Life Technologies).
Immunohistochemistry and fluorescence microscopy
The mice were deeply sedated with ketamine hydrochloride (100 mg/kg, intramuscularly) and 2% xylazine hydrochloride (10 mg/kg, Abbott Laboratories, USA), and intravascularly perfused through the left ventricle with phosphate-buffered saline (PBS, pH 7.4), followed by fixation with 4% paraformaldehyde (PFA). The vestibular sacculus, utriculus, and ampullae of the semicircular canal tissue were gently isolated, harvested, and fixed in 4% PFA overnight at 4 C, and then rinsed in PBS to remove any residual PFA. Immunohistochemistry was performed as previously described (Zhang et al., 2013) . Tissue samples were permeabilized in 0.5% Triton X-100 (Sigma) for 1 h and immunoblocked with a solution of 10% goat serum (alternatively 10% donkey serum) and 1% bovine albumin in 0.02 M PBS for 1 h. For immunofluorescence double labeling, tissues were blocked with 1% fish gelatin solution (G7765 Sigma) for 1 h. The specimens were incubated overnight at 4 C with the primary antibodies (listed in Table 1 ) diluted in 1% BSA-PBS. After 30 min washes in PBS, the samples were incubated with the secondary antibodies (listed in Table 1 ) for 1 h at room temperature. Capillaries were labeled with the lectin Griffonia Simplicifolia IB4 (GS-IB4) conjugated to Alexa Fluor 568 (catalog # I21412, Life Technologies). The tissues were washed for 30 min, mounted (H-1000, Vector Laboratories, USA), and visualized under an FV1000 Olympus laser-scanning confocal microscope. Controls were prepared by replacing primary antibodies with overnight incubation in 1% BSA-PBS.
Staining frozen tissue sections
Cochleae from young mice age 8e12d were isolated and fixed in 4% PFA overnight. After decalcification in bone decalcifier (DCO-DEQT, Decal Chemical Corporation, USA) overnight, the cochleae were dehydrated with 30% sucrose and embedded with OCT. Seven-micrometer sections of the cochleae were cut in the midmodiolar plane. The crysolides were washed with PBS for 15 min to remove the OCT component, and sections permeabilized in 0.5% Triton X-100 (Sigma) for 30 min and incubated in 10% normal goat serum (or other similar serum) diluted in PBS for 1 h to block nonspecific binding sites. The sections were incubated for 12e16 h with a primary antibody (for antibody information, see Table 1 ) at 4 C. Subsequently, the sections were exposed to an appropriate fluorescence-conjugated secondary antibody (Table 1) , and the GS-IB4 conjugated to Alexa Fluor 488, Alexa Fluor 568, or Alexa Fluor 647 at 37 C for 1 h. The tissues were washed for 30 min, mounted (H-1000, Vector Laboratories, USA), sealed in 20% glycerol, and visualized under an FV1000 Olympus laser-scanning confocal microscope. Controls were prepared by replacing primary antibodies with overnight incubation in 1% BSA-PBS.
Immunolabeling of primary cell lines
The cells at the third passage were fixed in 4% PFA (pH 7.2) for 15 min at room temperature, washed in 2 ml of PBS (three times for 10 min), permeabilized in 0.5% Triton X-100 for 3 min at room temperature, washed in 2 ml of PBS (three times for 10 min), and incubated with a blocking solution at room temperature for 1 h. The cells were then incubated with primary antibodies diluted in a 1% BSA-PBS solution overnight at 4 C, washed in 2 ml of PBS (three times for 10 min), and incubated with secondary antibodies diluted in 1% BSA-PBS solution for 1 h at room temperature. The cells were washed in 2 ml of PBS (three times for 10 min) and imaged under a confocal laser microscope. The antibodies are described in Table 1 .
Visualization of EC, PC, and PVM/M morphology
Cells were double labeled with Alexa Fluor 488-phalloidin diluted in 1% BSA-PBS solution for 1 h at room temperature (for visualization of the cytoskeleton) in addition to labeled for marker proteins. The cells were washed in 2 ml of PBS (three times for 10 min) and imaged under an FV1000 Olympus laser-scanning confocal microscope.
Reverse transcription-polymerase chain reaction (RT-PCR)
ECs, PCs, and PVM/Ms at the third passage were detached with a solution of trypsin-EDTA, collected in a 5 ml polypropylene roundbottom tube, and centrifuged at 300 g for 5 min. RNA was extracted with an RNeasy micro kit, cDNA synthesized with an RETROscript kit for RT-PCR, both used according to the manufacturer's instructions. The following reaction conditions were used for the RT-PCR: 44 C for 1 h; 92 C for 10 min; then hold at 4 C. Genes of interest included ng2, pdgfrb, desmin, cd34, glut1, vwf, gsta4, mitf, cd68, and cd11b. Forward and reverse primers (see Table 2 ) and reagents in the RETROscript kit were prepared according to the manufacturer's instructions. PCR products were separated and analyzed by 1.5% agarose gel electrophoresis.
Cell counts
The cells (first passage,~7e10 d) were detached from the culture dish with a solution of Trypsin-EDTA (catalog # T4049, Sigma) and counted with a hemacytometer (Model no. 1483, Hausser Scientific, Horsham, PA, USA). The mirror-like polished surface was carefully cleaned with ethanol, with a cover slip placed over the counting surface prior to adding the cell suspension. The diluted cell suspension (approximately 10 ml) was introduced into one of the V-shaped wells and allowed to run under the cover slip. Cell counts in 4 large corner squares were recorded, and care was taken to avoid count of obvious cell debris. Cell concentration per ml (and total number of cells) was determined using the following calculation: Cells per ml ¼ the average count per square Â the dilution factor Â 10 4 . The same procedure was done after 7e10 d (~third passage).
Purity assessment with fluorescence-activated cell sorting (FACS)
ECs, PCs, and PVM/Ms at the third passage were detached with a solution of Trypsin-EDTA (catalog # T4049, Sigma). The cells were gently washed in 2 ml of culture medium and centrifuged at 300g for 5 min at 4 C. The supernatant was carefully aspirated. The cell pellet (1 Â 10 7 cells/ml) was re-suspended in its own culture medium and incubated in the dark with different antibodies for 30 min at 4 C. ECs were incubated with CD34 (Table 1 ) at a concentration of 10 ml/10 6 cells (in 100 ml) for 30 min, washed in culture medium, and incubated with Alexa Fluor 568-conjugated goat antirabbit antibody (Table 1) for 20 min. PCs, incubated with phycoerythrin-conjugated rat mAb for PDGFRb (catalog # ab93534, Abcam) at a concentration of 0.5 mg/ml. Rat IgG phycoerythrin (catalog # ab37368, Abcam), at a concentration of 0.2 mg/ml, served as the isotype control. PVM/Ms were incubated with CD68 (Table 1) at a concentration of 10 ml/10 6 cells (in 100 ml) for 30 min, washed in culture medium, and incubated with Alexa Fluor 488-conjugated goat anti-rat antibody (Table 1) for 20 min. The cells were centrifuged at 300g for 5 min at 4 C and re-suspended in their own culture medium. The cells were analyzed as soon as possible after the final wash using a BD influx cell sorter.
Transwell monolayer permeability assay
Trans-endothelial permeability of the endothelial cell monolayer to FITC-dextran (MW, 70 kDa) was measured according to the manufacturer's instructions (catalog # ECM 644, vascular permeability assay kit; Millipore, Billerica, MA, USA) and described in our previous study (Neng et al., 2013b) . Briefly, FITC-dextran (diluted at 1: 40 in serum free medium) permeates through the endothelial cell monolayer into the basolateral chamber. The amount of dextran accumulating in the basolateral chamber is an indicator of permeability. FITC-dextran fluorescence was assessed with a multiwell microplate reader (TECAN GENios ELISA reader, TecanGroup Ltd.) at excitation and emission wavelengths of 485 and 535 nm.
In vitro matrigel angiogenesis assay
The newly generated primary cell lines were used to investigate 
Statistics
All statistical analyses were performed using Graph Pad Prism 5.0, with data presented as means ± SEM.
Results
Preparation of the vestibular end-organ explants and selective culture of cells in a specific culture medium
The vestibular end-organs were dissected from the inner ear under sterile conditions from mice aged P8eP12 and placed in cold artificial perilymph solution (Fig. 1A) . Vestibular explants, including the sacculus, utriculus, and three ampullae of the semicircular canal, were gently isolated. Cell lines were established from a pool of six end-organs (Fig. 1B) torn into tiny fragments under a sterile dissecting microscope. The tissue fragments were uniformly seeded in a collagen I coated tissue culture dish (Fig. 1C) . In general, multiple cell clusters form around the explanted fragments by day 1 or 2 ( Figure DeF) and spread over the entire surface of the dish by day 7e10 (Figures JeL).
The fragments of vestibular end-organs are comprised of a mixture of ECs, PCs, PVM/Ms, and other non-blood barrier component cells. To produce each primary cell line, selective growth medium in combination with additional treatments was used. For example, to produce the EC cell line, EC culture medium (see Materials and Methods) was used. In addition, BrdU, a pyrimidine analogue of thymidine, was added to the medium on day 2 and remained in the culture medium for an additional 4 days to maximally inhibit proliferation of non-EC cells such as fibroblasts (Sil and Sen, 1997) . With these medium selective methods, approximately 4 ± 1.5 Â 10 4 ECs were generated by day 7e10 in the initial (P1) stage (shown in Fig. 1a ). ECs were passaged at a split ratio of 1: 2 and incubated in EC growth medium at 37 C and 5% CO 2 . Cell growth was checked every 2 d under a phase-contrast microscope and the medium changed every 2 d for about 5e7 d (second passage, P2). Passage three was also done at a split ratio of 1: 2 and the cells grown an additional 5e7 d. Approximately 1.5 ± 0.5 Â 10 6 ECs were obtained in the third passage.
PCs were produced with PC culture medium with the addition of PEDF added to the culture medium on day 2 at a concentration of 100 nM. In our experiment, we found that clusters of PCs around the tissue fragments began to form by day 2 (shown in Fig. 1 E) . Individual cells were seen to spread rapidly by day 4 as shown in Fig. 1H . The proliferation was quite marked by day 7 with the formation of large colonies (Fig. 1K) . About 4 ± 1 Â 10 4 PCs were harvested by day 7e10 in the initial (P1) stage (Fig. 1b) . Passage of the PCs in the growth medium gave approximately 10 ± 1 Â 10 5 PCs in the third passage. PMM/Ms, a hybrid cell with characteristics of both macrophage and melanocyte, were produced in PVM/M culture medium containing HMGS (human melanocyte growth supplement). Approximately 10 ± 1 Â 10 4 PVM/Ms were generated by day 7e10 in the initial (P1) stage, as shown in Fig. 1c . The cells were then passaged and further grown in the specific PVM/M growth medium. The third passage yielded about 9 ± 1 Â 10 5 PVM/Ms.
3.2. Pre-validation of barrier component cell marker proteins in situ in surface prepared whole mounted vestibular end-organs
In this study, at least two marker proteins were used to identify each primary cell phenotype. The markers were pre-verified in situ in whole mounted tissue preparations ( Fig. 2A, F and 2K ). ECs are known to have different protein expression in different tissues. Endothelial cells express a variety of marker proteins in different tissues, including Von Willebrand factor (vWf), VE-cadherin (CD44), platelet/EC adhesion molecule-1 (PECAM-1, CD31), vascular endothelial growth factor receptors (VEGFRs), CD34, and glucose transporter 1 (Glut1) (Navone et al., 2013; Pusztaszeri et al., 2006) . Despite the variety of protein expression, Von Willebrand factor is considered the gold standard for EC identification (Middleton et al., 2005) . Expression of vWF in endothelial cells in human vestibular capillaries was previously reported by Masuda et al., (1997) ). In the present study, we identified ECs from the vestibular system in confocal microscope images on the basis of vWF expression. As a further confirmation, endothelial cell lines were assessed for expression of the marker protein Glut1. We also stained vessels with fluorescent conjugated GS-IB4 for visualization (Zhang et al., 2013) . We found the two EC markers prominently expressed in the capillaries of all three vestibular end-organs (Fig. 2BeE) .
PCs are smooth muscle like cells which, in different tissues, are heterogeneous in morphology and expression of marker proteins (Shi et al., 2008) . PCs were initially recognized on the basis of their distinctive shape and location, but are now most commonly identified with molecular markers such as a-smooth muscle actin (a-SMA), tropomyosin, desmin, nestin, and PDGFRb. PCs are not characterized by specific marker proteins. Rather the expression varies with the type of vessel. Thus PCs are best identified on the basis of multiple markers and morphological features (Armulik et al., 2005) . In this study, we identified PCs on the basis of PDGFR-b and desmin expression. Cochlear PCs express two marker proteins, desmin and NG2, which are not found in ECs and PVM/Ms of whole mounted stria vascularis tissue (Neng et al., 2013b) . In this study, we confirmed the vestibular PCs also express PDGFR-b and desmin by immunolabeling whole mounted tissue of the sacule and utricle with antibodies for the proteins (shown in Fig. 2GeJ) .
PVM/Ms in the stria vascularis are a hybrid cell type not fitting the phenotype of the classical macrophage (Neng et al., 2013b; Zhang et al., 2012) . PVM/Ms display characteristics of macrophage and melanocyte, and, correspondingly, express both macrophageand melanocyte marker proteins (Neng et al., 2013b; Shi, 2010; Zhang et al., 2012) . Like PVM/Ms in the stria vascularis, whole mounted PVM/Ms in the vestibular system express both protein phenotypes (Zhang et al., 2013) . In this study, PVM/M primary cultured cells were shown to express multiple cell marker protein genes, including GSTa4 (a melanocyte marker protein) and CD68 (a macrophage marker protein) (shown in Figures LeO) .
We have also double immunolabeled each cell phenotype in vivo for co-expression of two marker proteins and confirmed the three cell line marker proteins used for identifying the primary cell phenotypes are naturally expressed in the vestibular end-organs (as shown in Fig. 2QeS ). Furthermore, we pre-validated barrier component cell marker proteins in vivo in frozen tissue section preparations. The frozen tissue section preparation gives an overview of cell type distribution in different regions of the vascular apparatus [see attached Supplemental Fig. 1(a) , (b), and (c)].
Validation the PCs and PVM/Ms are not neurons of the vestibular end-organs in situ
The end organs are a mixture of cell types, including a large number of neurons which may express the same marker proteins as PCs and PVM/Ms express. Since this would present a problem for validating cell purity, we investigated whether any PC or PVM/M markers are also expressed by neurons. We triply labeled tissues with antibodies for a PC marker, the neuron marker NF-160, a marker widely used for neuron identification (Yang et al., 2000) , and GS-IB4, a marker for capillaries. We found that the fluorescence signal for the PC marker protein desmin (red, arrow, panel A of Fig. 3) does not overlap the fluorescence signal for NF-160 (green, arrow). Neither does the PVM/M marker protein, CD68 signal (red, arrow), overlap the signal for NF-160 (green, panel B of Fig. 3) . Our results confirm that neurons do not express desmin or CD68. Our result showed that some of the NF-160 positive cells were colabeled with COX10, a Schwann cell marker protein (shown in panel C and D of Fig. 3 ). We also found that those cells were not closely associated with vessels labeled with GS-IB4 (blue). Our results demonstrate the validity of using the neuron markers SOX10 and NF-160 for confirming the purity of vestibular cell lines in vitro. We also demonstrated that the PC marker desmin and PVM/M marker CD68 used for cell line identification were not expressed in neurons.
Validation of the cell line phenotype in vitro
The phenotype of PCs, PVM/Ms, and ECs was validated by immunostaining for marker proteins and verifying gene expression with RT-PCR. Fig. 4AeC are DIC images of cultured ECs, PCs, and PVM/Ms at the third passage. Fig. 4DeI shows the three cell lines immune-stained with antibodies for their respective marker proteins. Fig. 4JeL shows the corresponding RT-PCR gene analysis for each cell line. Genes for vWF, cd34, and glut1 were detected in the EC cell line. Genes of pdgfrb, desmin, and ng2 were detected in the PCs. Two melanocyte marker genes, mitf and gsta4, and two macrophage marker genes, cd68 and cd11b, were detected in the PVM/M cell line.
Validation of the cell lines by morphology
The phenotype of the ECs, PCs, and PVM/Ms was also validated by morphological analysis. Cells were stained with phalloidin and a specific cell marker for visualization. Fig. 5AeC are DIC images of cultured ECs, PCs, and PVM/Ms at the third passage. ECs have a flat, elongated, and generally cuboidal morphology, consistent with an earlier report (Gerrity et al., 1977) (Fig. 5D) . The PVM/Ms, previously identified as melanocytes (Zhang et al., 2012) , exhibit unique dendritic processes (Fig. 5E) . The cultured PCs display as large, flat, and stellate shaped cells with a broad filopodial morphology (Fig. 5F) . Fig. 5GeI demonstrate the characteristics of each cell type under high magnification.
Validation the PC and PVM/M cell lines are not neurons in the vestibular end-organs in vitro
Although we validated the PC and PVM/M cell line with immune-typing and gene analysis, we also further explicitly tested for the level of neuron contamination. We double labeled cell lines with either PC or PVM/M marker proteins and neuron or Schwann cell markers. The latter included NF-160 and SOX10, both widely used as markers for neurons and Schwann cells (Brehmer et al., 2002; Crisan et al., 2008; Nonaka et al., 2008; Yang et al., 2000) . We also examined neuron genes (NF-160), along with PC or PVM/M marker genes, to further confirm the PC or PVM/M phenotype. Fig. 6 shows that neither the PC marker PDGFRb nor the PVM/M marker CD68 co-labeled with NF-160 or SOX10. Multiple gene analysis showed the PC cell line to express PC marker genes including desmin, PDGFRb, and NG2, but not the neuron gene NF-160.
Assessment of cell purity
Cell purity was assessed and validated by FACS. Fig. 7AeC shows DIC images of trypsin-treated detached cells at passage three before FACS analysis. Fig. 7DeF shows confocal images of the detached cells with single marker labeling. The merged images in Fig. 7GeI shows the considerable overlap between marker protein labeled cells and the cells viewed under bright field.
The purity of each cell line, validated by FACS, is shown in bivariate histograms (Fig. 7JeL) . The mean purity from multiple FACS analyses is ECs 94 ± 5% (mean ± SEM, n ¼ 3), PCs 92 ± 2% (mean ± SEM, n ¼ 5), and PVM/Ms 93 ± 2% (mean ± SEM, n ¼ 3).
Utility of generated cell lines and validation of functional ECs and PCs
The primary cell lines enable direct study of intercellular interaction between ECs, PCs, and PVM/Ms in mono-and co-culture. In particular, BLB permeability of the EC-monolayer can be studied in vitro. The EC monolayer is shown in Fig. 8 , with its expression of tight junction proteins and characteristic "physical barrier." Fig. 8AeE respectively show cell-cell TJ protein expression of cytosolic zonula occludens-1 (ZO-1), occludin, VE-cadherin, and JAM1 at the transcript and protein levels. Permeability is assessed in the established endothelial monolayer by measuring the flux of 70 kDa fluorescent dextran across the EC-monolayer (shown in Fig. 8F ). The degree of EC-monolayer leakage is determined from the intensity of FITC-dextran fluorescence in the basolateral chamber. For example, low and stable endothelial monolayer permeability to FITC-dextran was found at day 7 following seeding with 200 ml vestibular ECs at a concentration of 3.4 Â 10 5 cells/ml on the transwell insert (Fig. 8F) .
The primary cell lines also enable investigation of angiogenesis. For example, the effect of interaction between ECs and PCs on the growth of endothelial tubules can be studied as demonstrated in Fig. 8GeJ . We found a dramatically different pattern of branch formation between models of ECs alone and ECs co-cultured with PCs. The examples in Fig. 8G demonstrate the effect of intercellular interaction on tubule formation in EC alone and EC/PC co-culture models at 12 h and 24 h after cell seeding in a 3D matrigel assay. We noticed a more robust sprouting angiogenesis in the presence of (BeE) tissues were double labeled with antibodies for the EC marker proteins Glut1 (green) and vWF (gray), while capillaries were labeled by GS-IB4 (red)and viewed under low and high magnification. EC markers are prominently expressed in the capillaries of all three types of vestibular end-organs. (GeJ) tissues were double labeled with antibodies for the PC marker proteins desmin (green) and PDGFRb (green), capillaries by GS-IB4 (red), and the cells viewed under low and high magnification. Vestibular PCs express both PDGFRb and desmin in immunolabeled whole mounted vestibular end-organs. (LeO) tissues were double labeled with antibodies for the PVM/M marker proteins CD68 (green) and GSTa4 (green), capillaries by GS-IB4 (red), and the cells viewed under low and high magnification. PVM/Ms in vivo are shown to exclusively express GSTa4 (melanocyte marker protein) and CD68 (macrophage marker protein). (QeS) representative confocal projection images show co-expression of two marker proteins respectively in PCs, ECs and PVM/Ms in vivo.
PCs. The cell cultureebased in vitro models offer a unique opportunity to study cell-cell interactions and role of individual cell barrier component cells in BLB function.
Discussion
The blood-labyrinth barrier (BLB) in the inner ear is a highly specialized capillary network that controls exchanges between blood and shields the inner ear from blood-born toxic substances and selectively passes ions, fluids, and nutrients to the ear, playing an essential role in the maintenance of inner ear homeostasis.
Blood-tissue barriers in the different regions of the inner ear make up the inner ear BLB system as a whole, including major blood-tissue barriers in the cochlear lateral wall and the bloodtissue barrier in the vestibular system. The physical blood-tissue barrier is comprised of ECs in the strial microvasculature, elaborated tight and adherens junctions, and accessory cells such as PCs, basement membrane (BM), and PVM/Ms, which together form a complex blood-tissue barrier with region-specific features (Shi, 2016) .
Previously, using a similar growth mediumebased approach, we obtained cochlear ECs, PCs, and PVM/Ms from the blood-tissue barrier in the stria vascularis of young mice (Neng et al., 2013a (Neng et al., , 2013b . These cell line models, in combination with different in vitro co-and triple-culture models, enable us to study the physical interactions between ECs, PCs, and PVM/Ms as well as to begin to understand the signaling between cells which regulates vascular permeability and provides a proper environment for hearing function in the cochlea (Neng et al., 2013a) .
Similar to the structure of the blood-tissue barrier in the stria vascularis, the blood-tissue barrier in the vestibular system is comprised of small volume end-organs with high anatomical complexity. Isolating PCs, ECs, and PVM/Ms from such small endorgan tissues is a substantial challenge. In this study, we have adapted the method for obtaining cell lines from the stria vascularis to the vestibular system, and we demonstrated the three cell lines can also be successfully established from vestibular tissue. Specifically, we collected utrical, sacule, and ampullar samples from young (P8-12 day old) mouse ear and manually minced them into "tiny" fragments. The cochlear cells in mice at this age are still highly proliferative. The "tiny" fragments of the "vestibular endorgan unit" are small enough to allow barrier component cells access to the culture medium. In this method, each barrier cell phenotype is selected and nurtured by choice of culture medium. Overall, the method produces an expanded and homogenous population of primary culture cells from the vestibular system. Most established methods for isolating blood/tissue barrier cells, including ECs and PCs, were developed on large tissue masses, such as brain, retina, skeletal muscle, skin, and fetal tissues (Abbott et al., 2012; Bryan and D'Amore, 2008; Katyshev and Dore-Duffy, 2012; Maier et al., 2010; Mogensen et al., 2011; Nees et al., 2012; Siow, 2012) . These methods are typically complex procedures, involving multiple steps of enzymatic digestion and gradient density centrifugation. The stringency of the procedure is also reported to cause some level of damage to barrier cells such as ECs (Bernas et al., 2010) . Our method, however, differs from previously published methods. This method does not require chemical digestion with collagenase. Sequential sieving steps are not required for separating large tissue fragments from single cells, nor are extra efforts required to collect appropriately sized fragments from the digested suspension. Primary cell types are generated from culturing in specialized media. For example, EC proliferation is specifically promoted by adding an endothelial growth factor to the culture medium. In contrast, non-specific EC growth can be inhibited by adding a synthetic nucleoside, BrdU, to the EC culture medium, as reported by Sil and Sen (1997) . On the other hand, PCs and PVM/Ms are produced by adding the growth factors PEDF or melanocyte growth factor to the medium. PEDF growth factor is essential for promoting vestibular PC growth (Neng et al., 2013b) , similar to what we found in PC cell lines developed from stria vascularis tissue (Neng et al., 2013a) . Also consistent with PVM/Ms in the stria vascularis, melanocyte growth factor potently and selectively stimulates PVM/M proliferation and growth.
In this study, each cell line (PC, PVM/M, and EC) was validated by immune-phenotyping for expression of cell marker proteins, profiling the gene-expression, and ascertaining the morphological characteristics. For example, PCs are smooth muscle like cells, which, in different tissues, are heterogeneous in morphology and express different marker proteins (Nehls and Drenckhahn, 1991) . Generally they cannot be identified by a single marker protein.
Instead, PCs are often identified on the basis of a set of marker proteins in combination with their morphological features as described by others (Armulik et al., 2005) . In this study, we identified the PCs on the basis of the expressions of PDGFRb and desmin marker proteins, which are also used to characterize PCs in the stria vascularis (Shi et al., 2008) . The end organs are known to contain a mixture of many unwanted cell types such as Schwann cells and neurons (Skaper et al., 1980) . To determine whether the generated PC cell line was contaminated by Schwann cells and neurons, we examined the cell line with a specific antibody for SOX 10, a marker protein for Schwann cells (Finzsch et al., 2010; Nonaka et al., 2008) , and a specific antibody for NF-160, a marker protein for neurons (Yang et al., 2000) . Our data shows that no detectable signals for both SOX10 and NF-160 in the generated primary PC cell line.
Similar to PCs, ECs are heterogeneous in protein expression from tissue to tissue. ECs express a variety of marker proteins, including vWF, VE-cadherin (CD44), platelet/EC adhesion molecule-1 (PECAM-1, CD31), vascular endothelial growth factor receptors (VEGFRs), CD34, and Glut1 (Navone et al., 2013; Pusztaszeri et al., 2006) . A comparative study by Middleton et al. (2005) found that vWFis the gold standard for EC identification in human tissue. vWF expression in vestibular capillary ECs, previously reported by Masuda et al. (1997) , was pre-validated in our immunofluorescence labeling. In our study, we validated the EC cell line from vestibular tissue based on expression of vWF and Glut1, the latter a second well-known EC marker protein, as well as on the basis of features such as a flat and generally cuboidal morphology, as shown in Fig. 5 .
PVM/Ms in the stria vascularis are a hybrid cell type that does not fit the phenotype of the classical macrophage (Neng et al., 2013b; Zhang et al., 2012) . The PVM/Ms display characteristics of macrophage and melanocyte, expressing both macrophage marker proteins and melanocyte proteins (Neng et al., 2013b; Zhang et al., 2012) . Like PVM/Ms in whole mounted stria vascularis tissue, PVM/ Ms in the vestibular system express both protein phenotypes (Zhang et al., 2013) . In this study, PVM/M primary culture cells were shown to express multiple cell marker proteins, including GSTa4 (melanocyte marker protein), Mitf (melanocyte marker protein), CD68 (macrophage marker protein), and CD11b (macrophage marker protein). Genes related to the proteins, including for expression of CD68 and GSTa4, were found in the PVM/Ms both in vivo and in vitro. The PVM/Ms were negative for NF-160, a marker protein often expressed in neurons (Ray et al., 1993; Raymond, 1987) .
The method of producing cell lines from vestibular tissue is technically practicable, requires no enzymatic treatment, and yields consistent results. However, when comparing the method in strialand vestibular tissue, the yield of primary cell lines generated from vestibular tissueis lower than from strial tissue. For example, approximately 1e2 Â 10 6 (ECs), 9e11 Â 10 5 (PCs), and 8e10 Â 10 5 (PVM/Ms) at P3 are obtained from the vestibular end-organs of six mice, compared to 2e3 Â 10 6 (ECs), 1e2 Â 10 6 (PCs), and 1.5e2.5 Â 10 6 (PVM/Ms) generated from the BLB of the stria vascularis (Neng et al., 2013b) . Nonetheless, the cell numbers obtained from the vestibular tissue of six mice is still sufficient for establishing an in vitro co-culture system. The individual roles of blood barrier component cells have rarely been investigated. The newly generated primary cell lines can be used in cell culture-based in vitro models, offering a unique opportunity to directly study the intercellular interactions between ECs, PVM/Ms, and PCs, the specific role of each phenotype on BLB permeability and angiogenesis, and tissue-specific characteristics of the cochlear blood/tissue barrier. For example, the cell lines established by this method will enable us to directly study how BLB integrity is controlled and how barrier integrity (e.g., vascular permeability) is influenced by different pathogens, such as viral infection, long thought to cause hydrops in the inner ear and M eni ere's disease. EC-monolayer leakage, reflecting vascular permeability, can be determined in an EC-monolayer by measuring the degree of extravasated FITC-dextran from the EC monolayer under physiological and pathological conditions. The mechanism related to the change in monolayer permeability can also be investigated by measuring the level of tight junction protein expression, including occludin, claudins, ZO-1, and the junctional adhesion molecules (JAMs, Jam1, 2, 3), in the EC monolayer, as shown in Fig. 8A . The newly generated primary cell line from the vestibular system will also allow us to study how cell-cell interactions affect vascular stability. For example, the role of PCs on EC proliferation and angiogenesis can be determined using a 3D matrigel matrix co-culture model, as shown in Fig. 8C .
The blood barrier integrity when it is normally functioning plays an essential role in maintaining ion and fluid homeostasis (flow volume, pressure, ion concentration, and osmolarity). Disruption of the BLB has been associated with hearing and balance dysfunction, including autoimmune inner ear disease, M eni ere's disease, and meningitis-associated labyrinthitis. As we gain better understanding of the control mechanisms in the blood barrier, particularly those responsible for its integrity, we may be able to improve treatments for patients who experience vestibular dysfunction due to vascular disruption. 
